These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30191780)

  • 21. Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review.
    Kini SD; Yiu DW; Weisberg RA; Davila JF; Chelius DC
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):467-471. PubMed ID: 30693788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia.
    Deshpande P; Bhat S; Karmarkar A
    J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
    Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
    Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary hemorrhagic telangiectasia/avastin.
    Davidson TM; Olitsky SE; Wei JL
    Laryngoscope; 2010 Feb; 120(2):432-5. PubMed ID: 19998344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 26. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA; Sami S; Babu S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
    Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
    Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the severity and progression of epistaxis in hereditary hemorrhagic telangiectasia 1 versus hereditary hemorrhagic telangiectasia 2.
    Hunter BN; Timmins BH; McDonald J; Whitehead KJ; Ward PD; Wilson KF
    Laryngoscope; 2016 Apr; 126(4):786-90. PubMed ID: 26372311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary haemorrhagic telangiectasia.
    Rimmer J; Lund VJ
    Rhinology; 2015 Sep; 53(3):195-203. PubMed ID: 26460394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epistaxis in hereditary haemorrhagic telangiectasia.
    Haitjema T; Balder W; Disch FJ; Westermann CJ
    Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary Haemorrhagic Telangiectasia with Severe Anemia and Recurrent CNS Infections.
    Peesapati N; Naidu P; Sunitha S; Sivaram PV
    J Assoc Physicians India; 2017 Sep; 65(9):96-98. PubMed ID: 29313587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
    Albarki H; Rimmer J
    Am J Rhinol Allergy; 2022 Nov; 36(6):890-896. PubMed ID: 35929049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.
    Pagella F; Pusateri A; Maiorano E; Spinozzi G; Ugolini S; Lizzio R; Mirabella R; Tinelli C; Olivieri C; Matti E
    Acta Otorhinolaryngol Ital; 2021 Feb; 41(1):59-68. PubMed ID: 33746224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life-threatening Anaemia in Patient with Hereditary Haemorrhagic Telangiectasia (Rendu-Osler-Weber Syndrome).
    Mikołajczyk-Solińska M; Leończyk K; Brzezina A; Rossa S; Kasznicki J
    Open Med (Wars); 2020; 15():134-138. PubMed ID: 32190736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features and treatment of hereditary hemorrhagic telangiectasia.
    Li S; Wang SJ; Zhao YQ
    Medicine (Baltimore); 2018 Aug; 97(31):e11687. PubMed ID: 30075565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A natural obturator in hereditary haemorrhagic telangiectasia.
    Soni-Jaiswal A; Woolford TJ
    J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of epistaxis in hereditary haemorrhagic telangiectasia (HHT) patients using pulsed dye laser and the effect of withholding treatment during the COVID pandemic.
    Jiang Y; Dennis SC; Brewin MP
    Lasers Med Sci; 2022 Oct; 37(8):3147-3153. PubMed ID: 35635649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osler-Weber-Rendu Syndrome in Relation to Dermatology.
    Orizaga-Y-Quiroga TL; Villarreal-Martínez A; Jaramillo-Moreno G; Ocampo-Candiani J
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):526-532. PubMed ID: 30975431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
    Joshi H; Woodworth BA; Carney AS
    J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.